Aristotle University Of Thessaloniki (AUTH)
Μελέτη της μικρο- και μακροκυκλοφορίας σε ασθενείς με διαβητική και μη διαβητική χρόνια νεφρική νόσο σταδίου 2-4
Abstract
dc:descriptionChronic kidney disease (CKD) has a high impact on the general population of developed countries and is associated with increased cardiovascular morbidity and mortality. One of the most common causes of CKD is type 2 diabetes mellitus (DM), which is also an independent risk factor for cardiovascular events, while the coexistence of CKD and diabetes further increases cardiovascular risk. Last years, it has been shown that in the development of cardiovascular disease in patients with CKD, active phenomena such as arterial stiffness and endothelial dysfunction are involved. Similarly, these disorders are very common in patients with diabetes, suggesting the presence of common pathophysiological mechanisms in the development of cardiovascular disease in these two groups of patients. This study is a cross-sectional study of patients-witnesses. The study included a total of 96 patients: 48 patients with diabetic CKD and 48 patients with non-diabetic CKD of stages 2, 3 and 4, who were divided equally in each of the studied stages of CKD. The effect of the presence of diabetes in the micro- and macrocirculatory disorders of patients with CKD was evaluated in the best possible way with a study of patients-witnesses, in which patients of both groups were matched in the other basic characteristics (age, sex, eGFR level). Microcirculation was assessed using video-capillaroscopy and carotid intima-media thickness. Patients also underwent a 24-hour ambulatory record of blood pressure and an analysis of office pulse wave. In the total study population, baseline capillary density (capillaries/mm2) was marginally lower in diabetic CKD patients in comparison to non-diabetic counterparts (30.5±3.6 vs 31.9±3.6, p=0.060). Diabetic patients presented significantly lower capillary density during postocclusive reactive hyperemia (36.3±3.8 vs 38.3±4.3, p=0.022) and during venous congestion (37.8±4.0 vs 39.8±4.2, p=0.015). The absolute increase in capillary density during postocclusive reactive hyperemia compared to baseline was again marginally higher in patients without diabetes, whereas % capillary recruitment was not different between groups. Across all CKD stages all studied capillaroscopy parameters are numerically lower in diabetic compared to non-diabetic CKD patients, but in CKD stages 2, 3a and 4 no statistically significant differences between the two groups were noted, probably due to the low number of individuals in each group. In stage 3b, however, significantly lower capillary density in diabetic subjects compared to non-diabetic was noted at baseline (p=0.044), during postocclusive hyperemia (p=0.037) and at venous congestion (p=0.022). In the total population, patients with DM had significantly higher 24-hour systolic BP (SBP) (132.1±10.7 vs 124.2±11.5; p=0.001) and pulse pressure (PP) (p<0.001), but similar 24-hour diastolic BP (DBP) (p=0.625) compared to patients without DM. Across all CKD stages, the same trends of higher SBP and PP in patients with DM compared to non-diabetic counterparts were observed, with differences in each group being marginally significant in many cases, obviously due to the small sample size within each CKD stage. In contrast, 24-hour DBP levels were similar between patients with and without DM in all comparisons across CKD stages.Additionally, in total, 24-hour SBP SD, wSD and ARV were higher in patients with DM compared to those without DM, however, 24-hour SBP CV was similar between the two groups. In addition, 24hour DBP SD, wSD, CV and ARV were again higher in patients with diabetes compared to those without DM. Diabetic patients had significantly higher 24-hour aortic SBP and PP, but similar 24-hour aortic DBP compared to patients without DM. Similarly, no differences between the two groups occurred in 24-hour aortic augmentation pressure, AIx, AIx(75) and PWV. No statistically significant difference in office SBP and DBP was observed between diabetic and non-diabetic subjects; however, office PP was significantly higher in diabetic compared to non-diabetic patients. Similarly, no differences between the two groups occurred in augmentation pressure, AIx and AIx(75). Notably, office PWV was higher in diabetics compared with non-diabetics, but this was marginally statistically significant. Additionally, there was no difference in carotid IMT between the two groups either in total population of our study or within any of the individual studied CKD stages. Basiline capillary density showed a statistically significant reduction with advancing CKD stages (p<0.001). During postocclusive reactive hyperemia (p<0.001) and during venous congestion (p<0.001), a similar decreasing trend in the number of perfused capillaries was evident from CKD stage 2 to CKD stage 4. In multivariate model, in order to identify possible factors associated with post-occlusive capillary density, three factors showed a significant association with capillary density; diabetes (β: -1.706, 95%CI: -3.176 to -0.236), and PTH (per pg/ml increase; β: -0.022, 95%CI: -0.036 to -0.008) had independent negative associations, whereas eGFR showed a positive association (per ml/min increase; β: 0.053, 95%CI: 0.004 to 0.101). Twenty-four hour brachial SBP, DBP and PP levels were similar across CKD stages. Additionally, 24-hour SBP and DBP SD, wSD, CV and ARV did not change between CKD stages. 24-hour aortic SBP, DBP, PP and augmentation pressure, AIx and AIx(75) were similar across CKD stages, while 24-hour aortic PWV showed a significant increasing trend with advancing CKD. Βrachial office SBP showed a significant increasing trend with advancing CKD, while brachial office DBP and PP levels were similar across CKD stages. Aortic office SBP showed a significant increasing trend with advancing CKD stages, while aortic office DBP and PP levels were similar across CKD stages. Office augmentation pressure, AIx, AIx(75) and PWV did not change between CKD stages. A relevant pattern towards increase with advancing CKD was also evident for carotid IMT values, without reaching statistical significance. In conclusion, this study suggests that capillary density during postocclusive reactive hyperemia and after venous congestion is lower in diabetic compared to non-diabetic CKD patients, a finding indicative that diabetes is an additional factor contributing to microcirculatory structural and functional impairment in CKD. These differences are more prominent in CKD stage 3b. As endothelial microcirculatory dysfunction is associated with adverse outcomes in both diabetes and CKD, further studies are needed to explore any potential effects of this difference on renal and cardiovascular disease progression. Additionally, this is the first study performing a direct comparison of ambulatory BP levels, BP profiles and BPV in patients with and without DM in CKD. It clearly shows that patients with diabetic CKD had higher 24-hour, day- and night-time SBP, compared to patients with non-diabetic CKD. Diabetes significantly affected the trajectories of SBP during the full observation period, and the daytime period, as well as of DBP during the daytime and night-time periods. Indexes of both systolic and diastolic BPV were higher in diabetic than non-diabetic patients, with the differences being greater within CKD Stage 3b. As both BP levels and BPV are independent risk factors for renal disease progression and cardiovascular events in CKD patients, this adverse BP profile may be a major mechanism for worse prognosis in patients with DM and CKD compared to patients with CKD alone. This study also showed that both structural and functional capillary density assessed with nailfold video-capillaroscopy progressively decreases with advancing CKD stages. Apart from reduced eGFR, the presence of diabetes and increased PTH levels are independently associated with this reduction and can play major roles in its development. Furthermore, this study suggests that, in parallel to arteriosclerosis and atherosclerosis in the large and medium-sized arteries, structural alterations at the microvascular level do exist in CKD, and deteriorate with renal function loss. Further studies with valid methodology should assess to what extent this capillary rarefaction affects the incidence of cardiovascular events of our patients.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Σχοινά, Μαρία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48444